Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Immatics | IMTX | Sep 26, 2024 | 11.73 | -0.59 |
Immersion | IMMR | Sep 26, 2024 | 8.68 | +2.24 |
Immix Biopharma | IMMX | Sep 26, 2024 | 1.59 | -3.64 |
ImmuCell | ICCC | Sep 26, 2024 | 3.61 | -0.28 |
Immuneering A | IMRX | Sep 26, 2024 | 2.61 | -11.22 |
Immunic | IMUX | Sep 26, 2024 | 1.50 | 0.00 |
ImmunityBio | IBRX | Sep 26, 2024 | 3.90 | +9.55 |
Immunocore ADR | IMCR | Sep 26, 2024 | 30.77 | +0.36 |
Immunome | IMNM | Sep 26, 2024 | 14.34 | +0.56 |
ImmunoPrecise Antibodies | IPA | Sep 26, 2024 | 0.67 | -1.49 |
Immunovant | IMVT | Sep 26, 2024 | 28.31 | -0.39 |
Immutep ADR | IMMP | Sep 26, 2024 | 2.27 | +2.71 |
Imperial Oil | IMO | Sep 26, 2024 | 68.68 | -2.33 |
Imperial Petroleum | IMPP | Sep 26, 2024 | 3.95 | -1.74 |
Imperial Petroleum A Pref | IMPPP | Sep 26, 2024 | 25.40 | +0.79 |
Impinj | PI | Sep 26, 2024 | 217.83 | +1.77 |
Imunon | IMNN | Sep 26, 2024 | 1.01 | 0.00 |
IN8bio | INAB | Sep 26, 2024 | 0.28 | -8.62 |
Inari Medical | NARI | Sep 26, 2024 | 40.68 | -1.93 |
Incannex Healthcare ADR | IXHL | Sep 26, 2024 | 2.04 | +0.99 |
Inception Growth Acquisition | IGTA | Sep 26, 2024 | 11.32 | 0.00 |
Inception Growth Acquisition Unit | IGTAU | Sep 26, 2024 | 11.14 | 0.00 |
Income Opportunity Realty Investors | IOR | Sep 26, 2024 | 18.00 | 0.00 |
Incyte | INCY | Sep 26, 2024 | 65.13 | +3.02 |
Indaptus Therapeutics | INDP | Sep 26, 2024 | 1.06 | -9.40 |
Independence Realty Trust | IRT | Sep 26, 2024 | 20.52 | -1.16 |
Independent Bank | IBCP | Sep 26, 2024 | 32.45 | -0.46 |
Independent Bank | INDB | Sep 26, 2024 | 59.08 | +0.37 |
Independent Bank Group | IBTX | Sep 26, 2024 | 56.63 | +0.62 |
India Bull 3X Direxion | INDL | Sep 26, 2024 | 77.28 | +0.81 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.